Dr. Devon Livingston-Rosanoff, MD, PhD

Dr. Livingston-Rosanoff practices at Sante' Foundation Medical Group in Fresno, California.

Dr. Livingston-Rosanoff's NPI, 1457747248, was assigned on April 8, 2015. Dr. Livingston-Rosanoff graduated from Emory School of Medicine in 2015. Dr. Livingston-Rosanoff's Wisconsin license number on file is 66549.

Dr. Livingston-Rosanoff's primary practice is Sante' Foundation Medical Group, at 6121 N Thesta St Suite 202 Suite 202, Fresno, CA 93710-5294. The practice phone is (559) 438-7390.

Dr. Livingston-Rosanoff's primary practice is Sante' Foundation Medical Group in Fresno, California. Dr. Livingston-Rosanoff is also affiliated with Community Regional Medical Center. The medical group on file is Santé Foundation Medical Group. Dmand AI also links Dr. Livingston-Rosanoff to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Livingston-Rosanoff practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Livingston-Rosanoff's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Livingston-Rosanoff is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Livingston-Rosanoff's licenses on file in 3 states: Wisconsin, California and Florida.

CMS data shows 312 Medicare services from Dr. Livingston-Rosanoff across 10 procedure codes in 2024, for 165 Medicare patients. Medicare paid $35,260 for them.

CMS counts 165 Medicare patients who saw Dr. Livingston-Rosanoff in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Livingston-Rosanoff's median patient age at 58, with 62% women.

In 2024, Dr. Livingston-Rosanoff wrote 188 Medicare Part D claims for 100 patients. 98% of them were for generic drugs. CMS names the drug for 156 of them, across 4 drugs with 11 or more claims each, at $1,525 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Livingston-Rosanoff for performance year 2024, reported as part of a group. Dr. Livingston-Rosanoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of colonoscopy by Dr. Livingston-Rosanoff, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Livingston-Rosanoff, published from 2011 to 2021. 2019 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Neoadjuvant Therapy. Dr. Livingston-Rosanoff's most frequent co-authors are Lee G. Wilke, MD, Heather B. Neuman, MD and Kara Vande Walle.

CMS Open Payments shows 27 general payments to Dr. Livingston-Rosanoff from 7 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 54% of the total. Intuitive Surgical, Inc. paid the most, $1,812.

Dr. Livingston-Rosanoff graduated from Emory School of Medicine in 2015.

Dr. Livingston-Rosanoff is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.